Follow-up Care After Treatment for Endometrial Cancer

July 11, 2012 updated by: Ottawa Hospital Research Institute

Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.

The purposes of this study are to examine the needs (symptoms, support, information) and satisfaction of women during follow-up in the community after completing treatment for endometrial cancer. This information will be collected from the perspective of the women themselves, their primary care providers (family physician or gynecologist) and the health care providers (oncologist, nurses, social worker, psychologist) at the cancer centre.

Study Overview

Status

Completed

Conditions

Detailed Description

Research Question How has this transfer in follow-up care impacted performance indicators?

  • Volume of follow-up care transferred
  • Percentage of women, who have required a re-entry consultation
  • Fiscal implication of this transfer of follow-up care

Patient stakeholders:

  • What are women's perceptions of the transition of follow-up care?
  • What are women's supportive care needs during the transition of follow-up care and ongoing needs?

Primary Care Practitioner stakeholders:

  • What are the primary care practitioners' perceptions of the process of transition of follow-up care?
  • What are the primary care practitioners' educational needs?
  • What are the primary care practitioners' perceptions of the process of re-entry for in women with suspected recurrence?

Tertiary Centre: Health care providers stakeholders

o What are the perceptions of tertiary health care providers about the transition of follow-up care?

Study Type

Observational

Enrollment (Actual)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Ottawa, Ontario, Canada, K1H 8L6
        • The Ottawa Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study will employ a convenience sample of women with endometrial cancer treated at the Ottawa Hospital Cancer Centre who have been discharged from follow-up after September 2005. Women will be identified from the Cancer Centre health records. The primary care providers will also be identified by health records as provided by the endometrial cancer patient when they registered with the TOHCC.

Description

Inclusion Criteria:

  • Participants- women diagnosed with endometrial cancer:

    • 18 years of age or older.
    • speak English or French
    • who have been treated (surgery and/or radiation therapy) at TOH.
    • who have been discharged from follow-up in the cancer centre in the past 6 months.

  • Participants-primary care provider practitioner:

    • providing follow-up care to at least one woman with endometrial cancer

  • Participants- health care providers at the tertiary centre :

    • physicians, nurses or allied health care providers whose primary responsibility are to provide care to women with gynecological cancer.

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Qualitative description of participants perception
Time Frame: after 6 month
after 6 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ottawa Hospital Research Institute

Collaborators

Ottawa Regional Cancer Centre

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

September 1, 2009

Study Completion (Actual)

February 1, 2010

Study Registration Dates

First Submitted

September 9, 2008

First Submitted That Met QC Criteria

September 9, 2008

First Posted (Estimate)

September 10, 2008

Study Record Updates

Last Update Posted (Estimate)

July 13, 2012

Last Update Submitted That Met QC Criteria

July 11, 2012

Last Verified

July 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OHRI 2008-361
  • 2008361-01H for OHREB

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endometrial Neoplasm

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe